# Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

> **NCT06967389** · — · RECRUITING · sponsor: **John Bauer** · enrollment: 50 (estimated)

## Conditions studied

- Obesity and Overweight
- Obese Adolescents
- Weight Management
- Weight Loss
- Cardiovascular Disease Risk Factor

## Interventions

- **DRUG:** Ozempic®

## Key facts

- **NCT ID:** NCT06967389
- **Lead sponsor:** John Bauer
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-12
- **Primary completion:** 2026-07
- **Final completion:** 2027-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06967389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06967389, "Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06967389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*